136 results on '"Klar, R"'
Search Results
2. Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells
3. Characterization and Assessment of CD26++ T Cells in the course of Haploidentical Stem Cell Transplantation: AB27
4. Compact design for high precision machine tools
5. Characterization and optimization of the dynamic tool path of a highly dynamic micromilling machine
6. TCR TRANSGENIC ALLO-RESTRICTED T CELLS DIRECTED AGAINST EWING SARCOMA ASSOCIATED ANTIGENS EZH2 AND CHM1: PH-O094
7. Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior
8. Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C
9. Combining gprof and event-driven monitoring for analyzing distributed programs: a rough view of NCSA mosaic
10. Medical expert systems: Design and applications in pulmonary medicine
11. Kommunikationsstandards in der Medizin: 2.2.1 | 2
12. Baricitinib inhibits radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis (RA) and an inadequate response to csDMARDs
13. LOW RATES OF RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE OVER 2 YEARS OF BARICITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
14. BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (CSDMARDS)
15. Recent developments in three-way analysis: A showcase of examples
16. Development and design of compact high precision machine tools
17. 280 - Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize and kill tumor associated antigen STEAP1+ tumour cells in vivo
18. 189 - Leukemia-associated Antigen Reactive T-cells in ATIR101, a Recipient-specific Allodepleted T-cell Product to Reduce Relapse Rates and GVHD after Haplo-HSCT
19. Critical success factors for a hospital-wide PACS
20. Numerical Simulations in Hydraulic Engineering.
21. The JANUS X-Ray Flash Monitor.
22. A Link-Layer Broadcast Service for SpaceWire Networks.
23. The unique observing capabilities of the Swift x-ray telescope.
24. The Swift X-Ray Telescope.
25. Readout modes and automated operation of the Swift X-ray Telescope.
26. The X-ray Telescope for the SWIFT Gamma-Ray Burst Mission.
27. Next-of-kin's perspectives of end-of-life care.
28. The cooperation of medical informatics, biometry and epidemiology.
29. Selected impressions on the beginning of the electronic medical record and patient information.
30. A comparison of approximate models for radiation in gas turbines.
31. Managing expectations between patient and nurse.
32. Distributed performance monitoring: methods, tools, and applications.
33. The Association of Inflammatory Bowel Disease and Leukemia-Coincidence or Not??
34. Ein Beitrag zur Pathogenese des Herpes corneae.
35. Distributed shared memory multiprocessor architecture MEMSY for high performance paralel computations.
36. Abstracts from the 4th ImmunoTherapy of Cancer Conference
37. Bridging from medical informatics, biometry and epidemiology to medical engineering.
38. Buchbesprechung: Was heißt und zu welchem Ende betreibt man medizinische Dokumentation?
39. E-learning in Oral and Maxillofacial Surgery: E-book and interactive case presentation with XML
40. OncoCase []
41. Recommendations for the implemantation of the new German medical curriculum (27.6.2002) in the subjects Epidemiology, Medical Biometry and Medical Informatics
42. Increased cholecystectomy rate after introduction of laparoscopic cholecystectomy.
43. Medical decision making and the retrieval of medical databases.
44. Wolfgang Giere's Farewell Symposium "Electronic Patient Information - Pioneers and MuchMore".
45. Computer-assisted teaching and learning in medicine
46. Diagnostic validity of serial CEA determinations in metastatic breast cancer.
47. Alleged Influence of Heavy Water on Mould Growth.
48. Characterization of the TLR9-Activating Potential of LNA-Modified Antisense Oligonucleotides.
49. Human angiotensin-converting enzyme 2-specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants.
50. Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.